Open company graph database — free web & API
Login

Sumitomo Pharma Switzerland GmbH

住友製薬スイス株式会社Alias
Ticker
—
Listed market
—
Country
Bangladesh
Employees (non-consolidated)
—
Related companies
15
§01

Basic information

BASIC
Head office
Office Location:
Chief executive
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

4
Manufacturing and sales of pharmaceuticalsDevelopment of regenerative medicine and cell therapy productsResearch and development of regenerative medicine and cell therapyDevelopment of digital health solutions and healthcare services
§04

Related companies

15 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Sumitomo Chemical (China) Co., Ltd.
Group Parent
Sumitomo Pharma Co., Ltd.
Group Parent
Altavant Sciences GmbH
Group
Enzyvant Therapeutics, Inc.
Group Subsidiary
Myovant Sciences, Inc.
Group Subsidiary
Sumitovant Biopharma, Inc.
Group Subsidiary
Urovant Sciences, Inc.
Group Subsidiary
Sumitomo Pharma America, Inc.
Group Subsidiary
Pfizer Inc.
Group
BehaVR, Inc.
Group
Drawbridge Health, Inc.
Group
Merck Sharp & Dohme Corp.
Group
Spirovant Sciences, Inc.
Group Subsidiary
Takeda Pharmaceutical Company, Limited
Group
Tsubota Laboratory, Inc.
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

10 EVENTS

Former Dainippon Pharmaceutical established on May 14, 1897 (Meiji 30). Osaka Pharmaceutical Co., Ltd. was founded by 21 influential pharmaceutical entrepreneurs in Dojima, Osaka.Sources

Former Sumitomo Pharmaceutical established on February 6, 1984 (Showa 59). Sumitomo Chemical Industry Co., Ltd. (now Sumitomo Chemical Co., Ltd.)'s research, development, and manufacturing divisions for pharmaceuticals, and the pharmaceutical sales division inherited from Inabata Sangyo Co., Ltd., the general agent for Sumitomo Chemical's pharmaceuticals, led to the founding of Sumitomo Pharmaceutical Co., Ltd.Sources

1993: New release of antihypertensive and angina treatment drug "Amrozin®".Sources

1995: New release of carbapenem antibiotic "MeroPen®".Sources

1999: Sumitomo Pharmaceutical America Limited established.Sources

Established in 2003, Sumitomo Pharmaceutical (Suzhou) Co., Ltd.Sources

2013: Established a subsidiary in Singapore (Sumitomo Pharma Asia Pacific Private Limited).Sources

2014: Established a joint venture company (Silegen Inc.) related to regenerative medicine products.Sources

2020: New release of atypical antipsychotic drug "Latzuma®" in Japan.Sources

Effective July 1, 2023, the US group companies were reorganized, leading to the inauguration.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑